SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,108,422 | -30.1% | 3,508,377 | +23.8% | 0.00% | -50.0% |
| Q3 2022 | $4,449,000 | -20.0% | 2,833,661 | +2.4% | 0.00% | 0.0% |
| Q2 2022 | $5,562,000 | +8.4% | 2,766,904 | +25.7% | 0.00% | 0.0% |
| Q1 2022 | $5,130,000 | -48.5% | 2,201,687 | +2.7% | 0.00% | -33.3% |
| Q4 2021 | $9,966,000 | -35.7% | 2,143,094 | +5.4% | 0.00% | -40.0% |
| Q3 2021 | $15,510,000 | -7.5% | 2,032,750 | +17.5% | 0.01% | -16.7% |
| Q2 2021 | $16,770,000 | +23.7% | 1,730,560 | +5.6% | 0.01% | +20.0% |
| Q1 2021 | $13,557,000 | +30.5% | 1,639,254 | +7.7% | 0.01% | +25.0% |
| Q4 2020 | $10,392,000 | -32.0% | 1,522,549 | +11.1% | 0.00% | -42.9% |
| Q3 2020 | $15,277,000 | +449.5% | 1,370,069 | +209.5% | 0.01% | +600.0% |
| Q2 2020 | $2,780,000 | +364.1% | 442,623 | +36.0% | 0.00% | – |
| Q1 2020 | $599,000 | -44.1% | 325,492 | +2.7% | 0.00% | -100.0% |
| Q4 2019 | $1,072,000 | +70.7% | 317,029 | +8.2% | 0.00% | – |
| Q3 2019 | $628,000 | -14.3% | 293,135 | +6.8% | 0.00% | – |
| Q2 2019 | $733,000 | -34.1% | 274,446 | +17.2% | 0.00% | -100.0% |
| Q1 2019 | $1,113,000 | +69.9% | 234,254 | -14.1% | 0.00% | 0.0% |
| Q4 2018 | $655,000 | -37.3% | 272,665 | +15.0% | 0.00% | 0.0% |
| Q3 2018 | $1,044,000 | -19.4% | 237,075 | +31.8% | 0.00% | 0.0% |
| Q2 2018 | $1,296,000 | +1293.5% | 179,939 | +903.1% | 0.00% | – |
| Q1 2018 | $93,000 | -41.1% | 17,939 | -55.0% | 0.00% | – |
| Q1 2017 | $158,000 | -19.4% | 39,855 | 0.0% | 0.00% | – |
| Q4 2016 | $196,000 | -36.6% | 39,855 | 0.0% | 0.00% | – |
| Q3 2016 | $309,000 | +37.9% | 39,855 | 0.0% | 0.00% | – |
| Q2 2016 | $224,000 | +4.2% | 39,855 | 0.0% | 0.00% | – |
| Q1 2016 | $215,000 | -38.2% | 39,855 | 0.0% | 0.00% | – |
| Q4 2015 | $348,000 | +3.9% | 39,855 | 0.0% | 0.00% | – |
| Q3 2015 | $335,000 | -53.6% | 39,855 | -2.7% | 0.00% | -100.0% |
| Q2 2015 | $722,000 | – | 40,955 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |